Literature DB >> 18653447

A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance.

Pey-Jium Chang1, Duane Shedd, George Miller.   

Abstract

The protein encoded by open reading frame 50 (ORF50) of Kaposi's sarcoma-associated herpesvirus (KSHV) functions as a transcriptional activator and in lytic viral DNA replication to mediate the switch from latent viral infection to the lytic phase. Here we identify regulatory regions of ORF50 protein that independently control DNA binding and abundance of the protein. One region contains a DNA-binding inhibitory sequence (DBIS) located between amino acids (aa) 490 and 535 of ORF50. A cluster of basic amino acids in this sequence is important in inhibiting DNA binding. The DBIS can function at the N or C terminus or internally in the ORF50 protein. Since the DBIS is functional in ORF50 protein purified from Escherichia coli, it is likely to work through an intramolecular mechanism. The second regulatory region, a protein abundance regulatory signal (PARS), consists of two components. Component I of the PARS overlaps the DBIS but can be differentiated from the DBIS by specific substitution of basic amino acid residues. Component II of PARS is located between aa 590 and 650. Mutation or deletion of either component results in abundant expression of ORF50 protein. When the two-component PARS was fused to a heterologous protein, Glutathione S-transferase, the fusion protein was unstable. Mutations in the DBIS or PARS impair the capacity of ORF50 to activate direct and indirect target viral promoters. Since these overlapping regulatory motifs are located in the C-terminal transactivation domain, they are likely to be important in controlling many actions of ORF50 protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653447      PMCID: PMC2546948          DOI: 10.1128/JVI.00862-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Transcriptional regulation: Kamikaze activators.

Authors:  D Thomas; M Tyers
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

2.  Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene.

Authors:  J Chen; K Ueda; S Sakakibara; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  A shared surface of TBP directs RNA polymerase II and III transcription via association with different TFIIB family members.

Authors:  Xuemei Zhao; Laura Schramm; Nouria Hernandez; Winship Herr
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

4.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.

Authors:  T Ragoczy; G Miller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus.

Authors:  Hongyu Deng; Arthur Young; Ren Sun
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

8.  Identification of a highly conserved domain in the androgen receptor that suppresses the DNA-binding domain-DNA interactions.

Authors:  Guo-Zhen Liu; Hua Wang; Zhengxin Wang
Journal:  J Biol Chem       Date:  2003-02-17       Impact factor: 5.157

9.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.

Authors:  Markus Sauer; Anne Catherine Bretz; Rasa Beinoraviciute-Kellner; Michaela Beitzinger; Christof Burek; Andreas Rosenwald; Gregory S Harms; Thorsten Stiewe
Journal:  Nucleic Acids Res       Date:  2008-02-11       Impact factor: 16.971

View more
  13 in total

1.  Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein.

Authors:  Pey-Jium Chang; Joseph Boonsiri; Shih-Shan Wang; Li-Yu Chen; George Miller
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

2.  Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Dirk P Dittmer
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

3.  Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator.

Authors:  Helen J Brown; Li Peng; Josephine N Harada; John R Walker; Steven Cole; Su-Fang Lin; Jerome A Zack; Sumit K Chanda; Ren Sun
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

4.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

5.  A virally encoded small peptide regulates RTA stability and facilitates Kaposi's sarcoma-associated herpesvirus lytic replication.

Authors:  Tareq Jaber; Yan Yuan
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

6.  Ser-634 and Ser-636 of Kaposi's Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites.

Authors:  Wan-Hua Tsai; Pei-Wen Wang; Shu-Yu Lin; I-Lin Wu; Ying-Chieh Ko; Yu-Lian Chen; Mengtao Li; Su-Fang Lin
Journal:  Front Microbiol       Date:  2012-02-22       Impact factor: 5.640

7.  KSHV Rta Promoter Specification and Viral Reactivation.

Authors:  Jonathan Guito; David M Lukac
Journal:  Front Microbiol       Date:  2012-02-14       Impact factor: 5.640

Review 8.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

Review 9.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

10.  Regulation of the Abundance of Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein by Oncoprotein MDM2.

Authors:  Tzu-Hsuan Chang; Shie-Shan Wang; Lee-Wen Chen; Ying-Ju Shih; Li-Kwan Chang; Shih-Tung Liu; Pey-Jium Chang
Journal:  PLoS Pathog       Date:  2016-10-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.